v3.26.1
STOCK BASED COMPENSATION (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2018
Aug. 31, 2009
Jun. 30, 2026
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2026
Dec. 31, 2024
Dec. 31, 2025
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period                     3,074,181      
Unamortized stock compensation expense               $ 6,100,000     $ 6,100,000      
Fair market value of shares percentage, description                     (i) 100% of the fair market value of a share of stock on the grant date, or (ii) with respect to awards under the 2019 Plan or 2022 Plan, 110% of the fair market value of a share of stock on the grant date in the case of a Participant then owning more than 10% of the total combined voting power of all classes of stock of the Company or any “subsidiary corporation” of the Company or any “parent corporation” of the Company. Options to employees, directors and consultants generally vest and become exercisable over a period not exceeding four years. Options typically expire ten years after the date of grant.      
Exercise price per share   $ 5.00                 $ 2.29      
Exercise price per share   $ 3.33           $ 4.22     4.22   $ 3.92  
Repricing costs   $ 1,300,000   $ 2,730,000               $ 2,720,000    
Weighted average exercise price                     $ 3.19      
Unvested stock option expense                     $ 10,200,000      
Intrinsic value for warrant shares outstanding               $ 0     $ 0      
Employees Directors and Key Advisers [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Exercise price range, lower range limit       $ 9.00                    
Exercise price range, upper range limit       10.50                    
Weighted average exercise price       $ 6.00                    
Performance Stock Units PSU [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Restricted stock units granted                     2,136,112      
Amortization expense               600,000     $ 1,000,000.0      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period                     938,069      
Restricted Stock Units R S U And Performance Stock Units P S Us [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Amortization expense                   $ 100,000      
Total expense                     $ 2,800,000      
Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares, issued 6,666,667             120,087 6,666,667 3,000,000        
2009 Plan [Member] | Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares granted             0              
2019 Plan [Member] | Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares granted           0                
2022 Plan [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Shares of common stock issued         2,800,000                  
Common stock outstanding percentage         5.00%                  
2022 Plan [Member] | Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares available for grant 1,906,957             10,089     10,089      
Number of service shares                     938,069      
2023 Inducement Plan [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Shares of common stock issued                           1,000,000
2023 Inducement Plan [Member] | Common Stock [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares available for grant               847,101     847,101      
Number of shares, issued     1,000,000                      
Inducement Plan [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Amortization expense               $ 70,000.00     $ 100,000      
Repricing costs   $ 700,000                        
2022 Employee Stock Purchase Plan [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of shares available for grant 381,391                          
Employee stock purchase plan description                     The Company’s 2022 Employee Stock Purchase Plan (ESPP) permits eligible employees to purchase Company shares on an after-tax basis in an amount between 1% and 15% of their earnings: (i) on May 16th of each year at a 15% discount of the fair market value of the Company’s common stock on November 17th of the previous year or May 16th of the then-current year, whichever is lower, and (ii) on November 15th of each year at a 15% discount of the fair market value of the Company’s common stock on May 17th or November 15th of the then-current year, whichever is lower. The ESPP includes an “evergreen” feature, which provides that an additional number of shares of common stock will automatically be added to the shares authorized for issuance under the ESPP on January 1st of each year, beginning on January 1, 2024 and ending on (and including) January 1, 2032. The number of shares added each calendar year will equal the lesser of 1% of the Company’s common stock outstanding on December 31st of the preceding calendar year or 2,100,000 or a lesser number as determined by the Board.      
Employee stock purchase, shares                     18,993      
Authorized and available, shares               1,571,939     1,571,939